NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

The full agenda for the 3rd Glioblastoma Drug Development Summit has officially been released!

3rd annual Glioblastoma Drug Development Summit
January 18-20, 2022
Boston, MA

Conference Day Two Thursday, January 20

Optimizing Immunotherapies for GBM Drug Development

Marnix Bosch
CTO
Northwest Biotherapeutics

11.40 am Immunotherapy of Brain Cancer: Past, Present and Future.

• Challenges of designing & evaluating clinical trials for
immunotherapies in the GBM field.
• Strategies to sensitize glioblastoma to immune therapies.
• Exploring immune therapy resistance in glioblastoma.

https://glioblastoma-drugdevelopment.com/whats-on/speakers/?utm_source=internal&utm_medium=email&utm_campaign=launch&utm_content=primary/em-1/ev-22295